Indication
Soft or connective tissue sarcoma
Soft or connective tissue sarcoma encompasses a heterogeneous group of rare malignant tumors arising from extraskeletal mesenchymal tissues, including muscle, adipose tissue, fibrous tissue, peripheral nerves, blood vessels, and deep fascial structures. Read more about Soft or connective tissue sarcoma
38 drugs 31 manufacturers
Drugs that treat it
Common Soft or connective tissue sarcoma therapies.
PAZOPANIB HCL
PAZOPANIB HCL
PAZOPANIB HCL
PAZOPANIB HCL
DOXORUBICIN HCL
DOXORUBICIN HCL
DOXORUBICIN HCL
DOXORUBICIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSoft or connective tissue sarcoma encompasses a heterogeneous group of rare malignant tumors arising from extraskeletal mesenchymal tissues, including muscle, adipose tissue, fibrous tissue, peripheral nerves, blood vessels, and deep fascial structures.
These neoplasms can develop in individuals of any age and occur throughout the body, most commonly involving the extremities, retroperitoneum, trunk, and head and neck.
Pathophysiologically, they originate from mesenchymal progenitor cells and are characterized by expansive local growth—often forming a false fibrous capsule with microscopic infiltrative extensions—alongside a tendency for local recurrence and hematogenous dissemination, predominantly to the lungs.
Clinically, they typically present as painless, progressively enlarging soft-tissue masses, though retroperitoneal or deep visceral lesions may remain clinically silent until they cause compression of adjacent structures.
- nih.gov
Soft or connective tissue sarcoma encompasses a heterogeneous group of rare malignant tumors arising from extraskeletal mesenchymal tissues, including muscle, adipose tissue, fibrous tissue, peripheral nerves, blood vessels, and deep fascial structures Pathophysiologically, they originate from mesenchymal progenitor cells and are characterized by expansive local growth—often forming a false fibrous capsule with microscopic infiltrative extensions—alongside a tendency for local recurrence and hem...
- nih.gov
Soft or connective tissue sarcoma encompasses a heterogeneous group of rare malignant tumors arising from extraskeletal mesenchymal tissues, including muscle, adipose tissue, fibrous tissue, peripheral nerves, blood vessels, and deep fascial structures These neoplasms can develop in individuals of any age and occur throughout the body, most commonly involving the extremities, retroperitoneum, trunk, and head and neck Pathophysiologically, they originate from mesenchymal progenitor cells and are ...
- nih.gov
Soft or connective tissue sarcoma encompasses a heterogeneous group of rare malignant tumors arising from extraskeletal mesenchymal tissues, including muscle, adipose tissue, fibrous tissue, peripheral nerves, blood vessels, and deep fascial structures These neoplasms can develop in individuals of any age and occur throughout the body, most commonly involving the extremities, retroperitoneum, trunk, and head and neck
- cancer.gov
These neoplasms can develop in individuals of any age and occur throughout the body, most commonly involving the extremities, retroperitoneum, trunk, and head and neck
- vicc.org
Clinically, they typically present as painless, progressively enlarging soft-tissue masses, though retroperitoneal or deep visceral lesions may remain clinically silent until they cause compression of adjacent structures
Personalize your experience
Follow Soft or connective tissue sarcoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.